期刊文献+

回回甘松饮对糖尿病肾病大鼠肾脏保护作用的实验研究 被引量:5

Protective effect of HuihuiGansong Liquid on diabetic nephropathy rats' kidney
下载PDF
导出
摘要 目的明确回回甘松饮(HGY)对糖尿病肾病大鼠的肾脏保护作用。方法采用高脂饲料联合链脲佐菌素诱导大鼠实验性糖尿病肾病模型,随机分为模型组、格列喹酮(阳性对照)组和HGY组,并设正常对照组、。比较给药后各组大鼠的体重、肾指数、24 h尿量、血糖、血肌酐、尿素氮、24 h尿蛋白的数值。结果给药后HGY组大鼠的肾指数、24 h尿量、血糖、血肌酐、尿素氮、24 h尿蛋白均明显低于模型组(P<0.01)。结论回回甘松饮对糖尿病肾病大鼠的肾脏具有一定的保护作用。 Objective To clarify the protective effect of HuihuiGansongLiquid (HGY) on diabetic nephropathy (DN) rats' kidney. Methods High-fat diet combined with streptozotocin was applied to establish experimental DN rat model. Normal control group, model group, positive control group and HGY group were set up. The rats'weight, kidney index, 24h urine volume, blood glucose, serum creafinine, urea nitrogen and 24 hurine proteinin each group were compared after treatment. Results After treatment, the kidney index, 24h urine volume, blood glucose, serum ereatinine, urea nitrogen and 24h urine proteinin the HGY group were all obviously lower than those in the model group (P 〈0.01). CondusionThe HGYhas some protective effect on diabetic nephropathy rats' kidney.
出处 《北京中医药》 2013年第11期873-875,共3页 Beijing Journal of Traditional Chinese Medicine
基金 国家自然科学基金资助项目(81202774)
  • 相关文献

参考文献5

  • 1Reutens AT.Epidemiology of diabetic kidney Disease[J].Med Clin North Am,2013,97( 1 ): 1-18.
  • 2南一,马英锋,袁玲,牛阳.“回回体质假说”的外延[J].中国民族医药杂志,2010,16(1):1-3. 被引量:10
  • 3Kushwaha S, Jena GB. Enalapril reduces germ cell toxicity in streptozotocin-induced diabetic rat: investigation on pos- sible mechanisms[J]. Naunyn Schmiedebergs Arch Pharma- col,2012,385(2): 111-124.
  • 4National Kidney Foundation.KDOQI clinical practice guide- lines and clinical practice recom menddations for diabetes and chronic kidney disease [J].Am J Kidney Dis,2007, 49: S1-18.
  • 5Soldatos G,Cooper ME,Diabetic nephropathy:important pathophysiologic mechanisms [J]. Diabetes Res Clin Pract, 2008,82(Suppl1):S75-79.

二级参考文献4

共引文献9

同被引文献49

  • 1赵永清.回医回药产业发展论著[M].北京:科学技术文献出版社,2008.
  • 2单于德,单利.回医“三子”生理特性与病理探讨[J].中国民族民间医药,2007,16(1):26-28. 被引量:9
  • 3赵昱,周丽波,董柳,陈良,仝小林.辛开苦降法治疗肥胖2型糖尿病的临床研究[J].中华中医药学刊,2007,25(12):2575-2578. 被引量:24
  • 4单于德.回药本草[M].宁夏:宁夏人民出版社.2005:29-189.
  • 5Daroux M, Prevost G, Maillard-Lefebvre H, et al. Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies [J]. Diabetes Metab,2010,36( 1 ) : 1-10.
  • 6National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice reeommenddations for diabetes and chronic kidney disease [ J ]. Am J Kidney Dis,2007,49 (2 Suppl 2 ) : S1-18.
  • 7Nalhan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes [J]. N Engl J Med Overseas Ed, 2005,353 ( 25 ) :2643-2653.
  • 8The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus[J]. N Engl J Med Overseas Ed. 1993.329(14) :977-986.
  • 9Hu C, Sun L, Xiao L, et al. Insights into the Mechanisms Involved in the Expression and Regulation of Extraeellular Matrix Proteins in Diabetic Nephropathy [ J ]. Curr Med Chem, 2015, 22 ( 24 ) : 2858-2870.
  • 10Huang X, Su YX, Deng HC, et al. Suppression of mesangial cell proliferation and cxtracellular matrix production in streptozotocin- induced diabetic mice by adiponectin in vitro and in vivo [ J ]. HormMetab Res, 2014,46(10) :736-743.

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部